Upper Circuit: This micro-cap pharma stock reported stellar Q3FY23 results! Upper Circuit: This micro-cap pharma stock reported stellar Q3FY23 results! In an aim to expand their product portfolio, the company is focusing on developing multiple manufacturing sites Bhavya Rathod / Monday, January 30, 2023 / Article rating: 3.7 They initiated contract manufacturing from three new locations this quarter and with this, they are currently manufacturing at nine locations across India